Activist Investor Saba Capital Nominates Director, Reduces Stake in Gabelli Dividend & Income Trust
Summary
Activist investor Saba Capital Management, holding 6.43% of shares, has nominated an independent trustee to the board of Gabelli Dividend & Income Trust and has also sold approximately $7.8 million worth of shares over the past 60 days.
Key Events
-
Activist Nomination
Saba Capital Management has formally nominated Andre Clemot as an independent trustee for election to the board at the 2026 annual meeting of shareholders.
-
Shareholder Stake
Saba Capital Management, L.P. and its affiliates beneficially own 5,694,804 common shares, representing 6.43% of the outstanding stock.
-
Recent Share Sales
Over the past 60 days, Saba Capital sold approximately 300,635 shares with an aggregate value of about $7.8 million, occurring while the stock traded near its 52-week high.
-
Indemnification Agreement
Saba Capital has agreed to indemnify the nominated trustee against losses incurred from litigation related to his nomination and proxy solicitation.
Analysis
This Schedule 13D/A filing reveals that Saba Capital, a significant shareholder, is actively seeking to influence the corporate governance of Gabelli Dividend & Income Trust by nominating a new independent trustee for the upcoming annual meeting. This indicates potential dissatisfaction with the current board or management and could lead to a proxy contest. Concurrently, Saba Capital has reduced its holdings by selling shares valued at approximately $7.8 million over the last two months. While the nomination signals an intent to drive change, the concurrent share sales, occurring near the stock's 52-week high, suggest the activist is also taking profits or rebalancing its portfolio, which could be interpreted as a mixed signal regarding their long-term conviction in the current strategy. Investors should monitor developments related to the proxy solicitation and the company's response to Saba Capital's activism.
At the time of this filing, GDV was trading at $28.12 on NYSE in the Unknown sector, with a market capitalization of approximately $2.5B. The 52-week trading range was $20.10 to $28.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.